Premier Price to Book Ratio 2012-2024 | PINC
Historical price to book ratio values for Premier (PINC) over the last 10 years. The current price to book ratio for Premier as of June 27, 2024 is 1.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Premier Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-06-27 | 18.37 | 1.00 | |
| 2024-03-31 | 21.86 | $18.35 | 1.19 |
| 2023-12-31 | 21.89 | $19.95 | 1.10 |
| 2023-09-30 | 20.84 | $19.66 | 1.06 |
| 2023-06-30 | 26.55 | $19.59 | 1.36 |
| 2023-03-31 | 30.81 | $19.65 | 1.57 |
| 2022-12-31 | 33.08 | $19.40 | 1.71 |
| 2022-09-30 | 31.90 | $19.04 | 1.67 |
| 2022-06-30 | 33.33 | $19.05 | 1.75 |
| 2022-03-31 | 33.07 | $18.93 | 1.75 |
| 2021-12-31 | 38.05 | $19.00 | 2.00 |
| 2021-09-30 | 35.63 | $18.98 | 1.88 |
| 2021-06-30 | 31.81 | $18.20 | 1.75 |
| 2021-03-31 | 30.77 | $18.11 | 1.70 |
| 2020-12-31 | 31.73 | $17.77 | 1.79 |
| 2020-09-30 | 29.52 | $17.49 | 1.69 |
| 2020-06-30 | 30.64 | $15.26 | 2.01 |
| 2020-03-31 | 29.25 | $14.78 | 1.98 |
| 2019-12-31 | 33.86 | $13.73 | 2.47 |
| 2019-09-30 | 25.85 | $13.51 | 1.91 |
| 2019-06-30 | 34.96 | $13.13 | 2.66 |
| 2019-03-31 | 30.83 | $12.96 | 2.38 |
| 2018-12-31 | 33.39 | $13.02 | 2.56 |
| 2018-09-30 | 40.93 | $12.62 | 3.24 |
| 2018-06-30 | 32.52 | $11.22 | 2.90 |
| 2018-03-31 | 27.99 | $10.51 | 2.66 |
| 2017-12-31 | 26.09 | $10.58 | 2.47 |
| 2017-09-30 | 29.12 | $10.82 | 2.69 |
| 2017-06-30 | 32.18 | $10.60 | 3.04 |
| 2017-03-31 | 28.45 | $-10.12 | -2.81 |
| 2016-12-31 | 27.14 | $-9.63 | -2.82 |
| 2016-09-30 | 28.91 | $8.54 | 3.39 |
| 2016-06-30 | 29.23 | $8.34 | 3.50 |
| 2016-03-31 | 29.82 | $8.10 | 3.68 |
| 2015-12-31 | 31.53 | $7.49 | 4.21 |
| 2015-09-30 | 30.73 | $6.99 | 4.39 |
| 2015-06-30 | 34.38 | $6.68 | 5.15 |
| 2015-03-31 | 33.59 | $6.50 | 5.17 |
| 2014-12-31 | 29.97 | $6.17 | 4.86 |
| 2014-09-30 | 29.38 | $5.71 | 5.15 |
| 2014-06-30 | 25.92 | $5.34 | 4.85 |
| 2014-03-31 | 29.46 | $4.98 | 5.91 |
| 2013-12-31 | 32.86 | $4.37 | 7.52 |
| 2013-09-30 | 28.34 | $50.47 | 0.56 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.926B | $1.336B |
| Premier, Inc. operates as a healthcare alliance. The company brings together hospitals, health systems, physicians and other healthcare providers primarily in the United States. It also maintains clinical, financial and outcomes databases. Premier, Inc. is headquartered in Charlotte, North Carolina. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.523B | 15.62 |
| Cencora (COR) | United States | $45.467B | 17.73 |
| ICON (ICLR) | Ireland | $25.839B | 24.39 |
| DiDi Global (DIDIY) | China | $20.560B | 0.00 |
| Avantor (AVTR) | United States | $14.550B | 21.42 |
| CochLear (CHEOY) | Australia | $14.235B | 0.00 |
| Natera (NTRA) | United States | $13.510B | 0.00 |
| Medpace Holdings (MEDP) | United States | $13.148B | 43.26 |
| Revvity (RVTY) | United States | $13.044B | 22.88 |
| Viatris (VTRS) | United States | $12.478B | 3.73 |
| Charles River Laboratories (CRL) | United States | $10.681B | 20.45 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.978B | 0.00 |
| Solventum (SOLV) | United States | $8.865B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.503B | 0.00 |
| HealthEquity (HQY) | United States | $7.335B | 47.10 |
| Organon (OGN) | United States | $5.295B | 5.02 |
| Bausch + Lomb (BLCO) | Canada | $5.197B | 20.80 |
| Doximity (DOCS) | United States | $5.160B | 36.14 |
| PACS (PACS) | United States | $4.601B | 0.00 |
| Life Times (LTH) | United States | $3.772B | 39.52 |
| Sotera Health (SHC) | United States | $3.369B | 16.53 |
| Surgery Partners (SGRY) | United States | $3.091B | 28.28 |
| GoodRx Holdings (GDRX) | United States | $2.885B | 109.86 |
| Progyny (PGNY) | United States | $2.725B | 46.92 |
| Agilon Health (AGL) | United States | $2.710B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.968B | 7.80 |
| NovoCure (NVCR) | Jersey | $1.897B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.854B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.720B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.501B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.207B | 0.00 | |
| CareDx (CDNA) | United States | $0.749B | 0.00 |
| Embecta (EMBC) | United States | $0.719B | 4.89 |
| InnovAge Holding (INNV) | United States | $0.713B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.696B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.608B | 6.45 |
| Auna S.A (AUNA) | Luxembourg | $0.594B | 0.00 |
| Sharecare (SHCR) | United States | $0.500B | 0.00 |
| Enhabit (EHAB) | United States | $0.430B | 42.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.410B | 0.00 |
| ModivCare (MODV) | United States | $0.359B | 6.71 |
| QDM (QDMI) | Hong Kong, SAR China | $0.353B | 9.24 |
| Sonida Senior Living (SNDA) | United States | $0.348B | 0.00 |
| DocGo (DCGO) | United States | $0.326B | 17.83 |
| LifeMD (LFMD) | United States | $0.279B | 0.00 |
| MultiPlan (MPLN) | United States | $0.272B | 0.00 |
| Beauty Health (SKIN) | United States | $0.235B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.208B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.187B | 0.00 |
| Biodesix (BDSX) | United States | $0.172B | 0.00 |
| So-Young (SY) | China | $0.108B | 52.00 |
| Pono Capital Two (PTWO) | United States | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.043B | 5.78 |
| Co-Diagnostics (CODX) | United States | $0.040B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Oncology Institute (TOI) | United States | $0.033B | 0.00 |
| Nutex Health (NUTX) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.021B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.019B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.017B | 0.00 |
| KindlyMD (KDLY) | $0.017B | 0.00 | |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |